Skip to main content

Table 5 Prescription of the indicated medication depending on service utilisation and sex (generalised linear models)

From: Sex differences in cardiologic medication provision for adults with coronary heart disease: an analysis of health claims data from 2018 to 2020 in Saxony-Anhalt, Germany

  

Odds Ratio

CI (95%)

Indicator 6

Patients with heart failure and prescribed beta blocker

Cardiologist

(ref. no cardiologist)

1.10

1.09; 1.11

DMP

(ref. no DMP)

1.06

1.05; 1.07

Male

(ref. female)

1.00

0.99; 1.01

Indicator 7

Patients after acute myocardial infarction and prescribed beta blocker

Cardiologist

(ref. no cardiologist)

1.09

1.06; 1.12

DMP

(ref. no DMP)

1.02

0.99; 1.05

Male

(ref. Female)

1.01

0.98; 1.04

Indicator 8

eligible Patients with prescribed statins

Cardiologist

(ref. no cardiologist)

1.14

1.14; 1.15

DMP

(ref. no DMP)

1.25

1.24; 1.26

Male

(ref. Female)

1.12

1.11; 1.13

Indicator 9

eligible Patients with heart failure and/or high blood pressure and prescribed ACE-inhibitors or AT-II antagonists

Cardiologist

(ref. no cardiologist)

1.06

1.06; 1.07

DMP

(ref. no DMP)

1.03

1.03; 1.04

Male

(ref. female)

1.02

1.02;1.03

  1. CI = Confidence interval